PBM’s role in enhancing energy and vitality has been validated through rigorous research. It primarily works by augmenting mitochondrial function, leading to increased ATP production. Both low-level laser therapy and light-emitting diode therapy, individually or in combination, spanning a wavelength range from 655 to 950 nm, have shown positive outcomes (Vanin et al, 2017).

Research in animal models has demonstrated that PBM can improve muscle performance, recovery and ATP production (Ferraresi et al, 2015).

Human clinical studies by Ferraresi et al. (2016) consistently found that PBM, paired with strength training, enhances muscle mass and athletic performance while it reduces inflammation, oxidative stress, as evidenced through numerous assessments including but not limited to muscle biopsies (Ferraresi et al. 2016). Similar outcomes were reported in a study to High-Level Soccer Players which concluded that preexercise PBMT acts positively on various functional aspects and biochemical markers while in parallel, it exhibits an antioxidant effect, decreasing exercise-induced oxidative stress and consequently enhancing athletic performance (Tomazoni et al, 2019).

Moreover, PBM may enhance motor performance in targeted muscle groups, irrespective of the duration post-treatment (Carvalho et al, 2021), and enhance running performance while improve running economy (Lanferdini et al, 2021).

Given its pronounced effects, some scientists even questioned if international regulatory authorities should contemplate its permissibility in athletic competition! (Ferraresi et al. 2016).

There’s a growing excitement in the medical community about Transcranial Photobiomodulation (tPBM), which is considered a noninvasive brain stimulation method. This isn’t just due to its potential in enhancing brain metabolism and amplifying cellular signaling via a non thermal mechanism (Dmochowski et al, 2020), but also its efficacy in combatting cognitive decline. The truly intriguing part? Even young, healthy adults are finding their cognitive performance enhanced through this treatment (Salehpour et al, 2019).

tPBM’s efficacy isn’t limited to just human trials. Research has included insightful studies on rodent models (Cardoso et al, 2021) and canines (Dewey et al, 2022). In human trials, the results have been encouraging, with individuals with cognitive disorders demonstrating improvements post-treatment (Lee et al, 2023).

Moreover, there is some evidence that (tPBM) can enhance cognitive efficiency in older adults, alleviating anxiety and depressive symptoms in those with mild cognitive impairment while improving frontal lobe functions (Lee et al, 2023; Cheung et al, 2023).

Important: Research on transcranial PBM devices has indicated potential benefits in cognitive enhancement and brain health. While our panels do expose the head to light, it’s important to note that the effects might differ from targeted transcranial PBM.